Glyxambi
Empagliflozin and linagliptin tablets for type 2 diabetes. Empagliflozin removes sugar in urine, linagliptin boosts insulin after meals.
- Category
- Diabetes Management
- Active ingredients
- Empagliflozin · Linagliptin
- Route
- Oral use
- Form
- Tablet
- Strengths
- 10mg + 5mg
This listing uses Glyxambi as a reference name. A generic equivalent is supplied; its exact brand and manufacturer are confirmed before supply.
Prescription and consultation requirements for Glyxambi vary by destination and are determined by the fulfilment partner.
Glyxambi details
- Condition
- Type 2 Diabetes Mellitus
- Alternative names
- empagliflozin, linagliptin
- Therapeutic class
- SGLT2 Inhibitor, DPP-4 Inhibitor Combination
- Pharmacological class
- Antidiabetic Combination
- Contraindications
- severe renal impairment; end-stage renal disease; diabetic ketoacidosis
- Minor side effects
- increased urination; stuffy nose; nausea
- Moderate side effects
- urinary tract infection; genital yeast infection; joint pain
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Prescription-only medicine (POM)
- Originator
- Boehringer Ingelheim
- Onset Time
- 1–2 weeks
- Duration
- 24 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- Insulin; Diuretics; Rifampin
- Age restrictions
- Approved for adults.
Serious side effects
diabetic ketoacidosis, requires immediate medical attention; acute pancreatitis, requires immediate medical attention; fournier's gangrene, requires immediate medical attention
Patient summary
Empagliflozin and linagliptin tablets for type 2 diabetes. Empagliflozin removes sugar in urine, linagliptin boosts insulin after meals.
Mechanism of action
Empagliflozin promotes renal glucose loss while linagliptin increases active incretin hormones to boost insulin output.
Pregnancy and breastfeeding
Pregnancy: Avoid during second and third trimesters. Breastfeeding: Not recommended.
What you will receive
Glyxambi is used here as a reference originator brand name to identify the medicine. We are not affiliated with the brand owner, and this listing does not offer the originator product.
- The supplied product is a generic equivalent containing Empagliflozin / Linagliptin, not the originator brand shown as the reference.
- The exact generic brand, manufacturer and dispatch location are confirmed based on the product, destination and available manufacturer or partner warehouse.
- Check the final product details at checkout before confirming an order.